Thanks for posting the trial dave sss - it gives some idea of the time to be expected for the earliest possible trial termination at the first of 3 interim analyses. ie. "...three interim analyses for stopping accrual early for efficacy and futility when 30%, 45% and 60% of the 300 patients have reached the primary endpoint using Bayesian predictive probabilities."
So when at least 100 patients are available for assessment for "...Number of all-cause mortality within 30 days of randomization."
"...Bayesian predictive probabilities can be used for interim monitoring of clinical trials to estimate the probability of observing a statistically significant treatment effect if the trial were to continue to its predefined maximum sample size...."
So the first interim analysis will hopefully be released in first 2 weeks of June and if they align with the original results, the trial will end.
I wonder what cut-off percentage will trigger the NIH to recommend full Remestemcel-L backing and deployment as recommended treatment for moderate-severe Covid-19 ARDS?
Apologies for repetition or repeat of basics - I'm noob and so doing think out loud noob research.
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2020
MSB Trading - 2020, page-7170
-
- There are more pages in this discussion • 15,991 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 5440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | 1.460 |
2 | 19558 | 1.455 |
5 | 49977 | 1.450 |
5 | 102249 | 1.445 |
2 | 30389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 5440 | 3 |
1.470 | 22187 | 2 |
1.475 | 84389 | 3 |
1.480 | 118230 | 9 |
1.485 | 96793 | 8 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online